Protagenic Therapeutics, Inc.\new Interest Expense Nonoperating
Protagenic Therapeutics, Inc.\new (PTIX) reported Interest Expense Nonoperating of $107.68 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2025-03-31
- Protagenic Therapeutics, Inc.\new interest expense nonoperating for the quarter ending 2023-12-31 was $12.85K.
- Protagenic Therapeutics, Inc.\new interest expense nonoperating for the quarter ending 2023-09-30 was $31.96K.
- Protagenic Therapeutics, Inc.\new interest expense nonoperating for the quarter ending 2023-06-30 was $31.61K.
- Protagenic Therapeutics, Inc.\new interest expense nonoperating for fiscal 2023 was $107.68K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2023-12-31 | $12.85K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $44.81K derived: sum of 2 quarters · filed 2025-03-31 | $76.42K derived: sum of 3 quarters · filed 2025-03-31 | $107.68K 10-K · filed 2025-03-31 |
| 2023-09-30 | $31.96K 10-Q · filed 2024-11-14 | $63.57K derived: sum of 2 quarters · filed 2024-11-14 | $94.83K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $31.61K 10-Q · filed 2024-08-14 | $62.87K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |